Moscow: The Ministry of Health of the Republic of Belarus, the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), announce the beginning of vaccination with Russian Sputnik V vaccine in Belarus.
The first batch of the vaccine arrived in Belarus today.
Belarus was the first country to officially register Sputnik V after Russia.
The registration certificate was granted on December 21, 2020. On October 1, Belarus was also the first foreign country to begin clinical trials of Sputnik V.
Vaccination of volunteers was conducted as part of double-blind, randomized, placebo-controlled clinical trials in eight medical institutions selected as research centers in Belarus.
RDIF and its partners are jointly working on establishing local production of Sputnik V in Belarus. On November 11, 2020, RDIF and the Belpharmprom holding company signed a cooperation agreement to prepare the pharmaceutical company’s production facilities for the production of the vaccine.